Comments
The short-term outlook for Glenmark Pharmaceuticals is bullish. The stock has been moving up consistently over the last one week marks the beginning of a new leg of upmove. The stock has been in a strong uptrend since February. Strong support is in the ₹610-600 region. Any intermediate dips can be limited to ₹600. We can expect fresh buyers coming into the market in the ₹610-600 region.
Glenmark Pharmaceuticals share price can rise to ₹675-680 over the next two-three weeks or even earlier than that. Traders can go long now. Accumulate on dips at ₹615. Keep the stop-loss at ₹590. Trail the stop-loss up to ₹636 as soon as the stock moves up to ₹645. Move the stop-loss further up to ₹655 when the price touches ₹665. Exit the long positions at ₹680.
(Note: The recommendations are based on technical analysis. There is risk of loss in trading.)
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.